Skip to main content
Premium Trial:

Request an Annual Quote

Europroteome in Collaboration with Altana Pharma

NEW YORK, July 1 (GenomeWeb News) - Berlin-based Europroteome and Altana Pharma have entered a collaboration to evaluate approaches to molecular profiling of tissue specimens from cancer patients.

Europroteome will apply its proprietary collection of purified cancer cells to analyze molecular expression of panel of cancer targets, which will then be compared with clinical data to assess disease-associated expression signatures. This data will be applied to define molecular targets for the development of therapeutics and diagnostics.

Financial terms were not disclosed.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.